Skip to content
Coming soon
  • Agriculture Tech
  • AI Agents & Models
  • Autonomy
  • Avatars & Digital Humans
  • Biotech / Synthetic Biology
  • Blockchain / Crypto
  • Brain-Computer Interfaces
  • Climate Tech
  • Cloud & Edge Computing
  • Commerce
  • Cybersecurity
  • Data Infrastructure
  • Defense
  • Digital Identity
  • Education Tech
  • Energy
  • Fashion & Textiles
  • Food Tech
  • Healthcare Systems
  • Longevity & Human Enhancement
  • Manufacturing
  • Materials Science
  • Mobility
  • Quantum Computing
  • Semiconductors
  • Smart Homes
  • Space Tech
  • Spatial Computing
  • Voice & Conversational Interfaces
  • Wearables
Archived

Nuance Communications (Microsoft) was absorbed into Microsoft Dragon Copilot — this page is preserved as an archive. Visit fobi.com for current frontier-tech coverage.

Nuance Communications (Microsoft)

Acquired by Microsoft · 2022 · $19.7B
Nuance's DAX Copilot uses ambient AI to automatically draft clinical notes from patient-provider conversations, integrated deeply into Epic and other EHRs. Acquired by Microsoft for $19.7B in 2022. DAX Express launched in 2023 using GPT-4. Serves 600,000+ clinicians. Deepest EHR integration moat via Epic partnership.
DAX is the incumbent ambient scribe deployed across the most health systems; Microsoft's 2022 acquisition at $19.7B made it the anchor of the clinical AI documentation market.
nuance.com Ambient Clinical AIUnited States flagUnited Statesacquired

At a glance

Total raised
$20.0B
last round acquired
Headcount
1k-5k
approximate · public range
Headquarters
Burlington
United States flagUnited States
Founded
1992
34 years active
Status
Acquired
by Microsoft
Subsector
Ambient Clinical AI
Ambient Clinical AI
For subscribers

Subscribe to see the full profile

Including Funding rounds, Bull / Bear thesis, Stock + earnings, Roster changes, Patents, News, and Open roles.

Founding
50% off
$5
/month
 
94 of 100 spots left
Full
$10
/month
 
Available once all 100 Founding Member spots are claimed.
Get full access

Already subscribed? Sign in →